AC
NEO icon

Allstate Corporation’s NeoGenomics NEO Stock Holding History

Allstate Corporation’s Portfolio NEO Stock Details NEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$170K Buy
+11,649
New +$112K ﹤0.01% 1306

Other funds holding NEO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
GF
Greenhouse Funds Baltimore, Maryland $1.96B AUM 36.47% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return

Allstate Corporation's NEO Position: Q2 2026 in Review

Allstate Corporation opened a new position in NeoGenomics (NEO) in Q2 2026: 11,649 shares worth $170K. The stake represents ﹤0.01% of the portfolio and ranks #1306 among its holdings.

266 funds tracked by Wall St. Rank hold NEO as of Q2 2026.

  • Allstate Corporation held 11,649 shares of NeoGenomics worth $170K as of Q2 2026.
  • NeoGenomics was a new Allstate Corporation position in Q2 2026.
  • NeoGenomics made up ﹤0.01% of Allstate Corporation's portfolio in Q2 2026, its #1306 holding.
  • 266 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2026.

Based on Allstate Corporation's 13F filing for Q2 2026, filed 13 Aug 2026.